Clinical Trial Update: Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of MUCIPLIQ in reducing radio-chemotherapy-induced mucositis in patients with oral cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma in Situ of the Upper Respiratory Tract
• Oral Cancer
• Oral Mucositis

Drugs mentioned

• MUCIPLIQ

Snippet

Sponsor: Organ, Tissue, Regeneration, Repair and Replacement | Conditions: Oral Mucositis, Carcinoma in Situ of Upper Respiratory Tract | NA | Status: COMPLETED